RT Journal Article
SR Electronic
T1 A retrospective study of the effects of COVID-19 Non-pharmaceutical interventions on Influenza in Canada
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.02.16.24302930
DO 10.1101/2024.02.16.24302930
A1 Betti, Matthew I
A1 MacTavish, Heather
A1 MacIntyre, Kenzie
A1 Zadeh, Paniz
YR 2024
UL http://medrxiv.org/content/early/2024/02/18/2024.02.16.24302930.abstract
AB The COVID-19 pandemic had a significant impact on endemic respiratory illnesses. Through behavioural changes in populations and government policy, mainly through non-pharmaceutical interventions (NPIs), Canada saw historic lows in the number of Influenza A cases from 2020 through 2022. In this study, we use historical influenza A data for Canada and three provincial jurisdictions within Canada: Ontario, Quebec and Alberta to quantify the effects of these NPIs on influenza A. We aim to see which base parameters and derived parameters of an SIR model are most affected by NPIs. We find that the effective population size is the main driver of change, and discuss how these retrospective estimates can be used for future forecasting.Competing Interest StatementThe authors have declared no competing interest.Funding StatementYesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data are all publicly available through Canada, Ontario, Quebec and Alberta health portals. All portals are cited in the text.